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In recent years there has been an increased interest in
using biosensors for the recognition and monitoring of
molecule interactions. DNA sensors and gene chips are
particularly relevant for directly applying the infor-
mation gathered from the genome projects. In this
work electrochemical techniques are used to develop
methodologies to detect DNA polymorphisms in hu-
man genes using cytochrome P450 3A4 (CYP3A4) as a
model gene. CYP3A4*1B oligonucleotides were immo-
bilized on the surface of a gold electrode and hybridized
with fully complementary oligonucleotide sequences
as well as with mismatched sequences corresponding
to the CYP3A4*1A reference sequence. The methodol-
ogy developed is based on double-stranded DNA’s abil-
ity to transport charge along nucleotide stacking. The
perturbation of the double helix pi-stack introduced by
a mismatched nucleotide reduces electron flow and can
be detected by measuring the attenuation of the charge
transfer. The methodology developed could identify
CYP3A4*1A homozygotes by the 5 µC charge attenua-
tion observed when compared with DNA samples con-
taining at least one CYP3A4*1B allele. Clin Chem Lab
Med 2003; 41(4):475–481
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Abbreviations: CC, chronocoulometry; CV, cyclic voltam-
metry; CYP, cytochrome P450; ds, double-stranded; MB,
methylene blue; ODN, oligonucleotide; PBS, phosphate
buffered saline; RFLP, restriction fragment length poly-
morphism; SNP, single nucleotide polymorphism; ss,
single-stranded.
Introduction
One of the greatest challenges of modern biomedicine
is the integration of new genetic information into pro-
cedures that can be implemented in rapid, cost effec-
tive, and reliable methods to genotype and to identify
gene function, in order to be used as diagnostic tools in
disease settings.
DNA sensors are particularly relevant for directly ap-
plying the information gathered from genome projects
and polymorphism databases. Such devices are ex-
pected to have a considerable impact on diagnostic and
health care in the near future since analysis through-
puts can be increased several-fold with complete data
standardization (1–3). Polymorphism identification, se-
quence recognition, pathogen identification, expres-
sion profiling, and mutation detection are examples of
current applications of DNA sensors (4–11).
Briefly, in DNA sensors a solid surface (the sensor
surface) is programmed with specific single-stranded
DNA (ssDNA) sequences designed to probe samples
and recognize particular gene loci through comple-
mentary hybridization with target samples. The critical
issue in DNA sensing is the generation of a sensitive
and selective signal to measure the hybridization
analysis result (12). In the majority of the current DNA
sensor applications this is achieved indirectly by gath-
ering a signal generated by specific reporter groups,
usually a fluorescent molecule, used to label the target
molecules. These approaches require labeling the
samples with the reporter groups prior to the sensing
reaction, which constitutes a common source of irre-
producibility and contamination and is critical for the
sensitivity of the overall analysis (12, 13). To avoid such
bottlenecks, the use of methodologies to directly mea-
sure the hybridization analysis results without involv-
ing sample pre-treatment is desirable (12).
From such a perspective, interest in electrochemical
detection of DNA hybridization has recently increased.
The electrochemical activity of nucleotide residues in
DNA and RNA (8, 14, 15), particularly adenine and gua-
nine, as well as the long range ability of double-strand
DNA (dsDNA) to transport charge through the double
helix pi-stack (16–18), enable the direct and real-time
transduction of hybridization reactions (9, 10).
Different electrochemical transducing methodolo-
gies are described in the literature. Cyclic voltammetry
(CV), square wave voltammetry and chronocoulometry
(CC) are the most common techniques in the detection
of hybridization reactions in gold, mercury, and carbon
paste electrodes (6–15).
In this work electrochemical techniques are used to
develop methodologies for detecting DNA polymor-
phisms in human genes potentially involved in the
modulation of individual cancer susceptibility as well
as therapeutic efficacy. The electrochemical activity of
a DNA intercalator is used to measure the variations on
the charge transport through the DNA pi-stack occur-
ring when mismatched nucleotides are present as in*E-mail of the corresponding author: gferrei@ualg.pt
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the case of polymorphic locations (9, 10, 19). This DNA
intercalator is reduced by the electron flow through
DNA and releases the received electrons to an electro-
chemically active compound in the solution. An elec-
trochemical catalytic cycle is therefore generated that
is fed by electron flow from the electrode (9, 10, 19)
(Figure 1). To detect this electron flow the most conve-
nient technique is CC (9, 10). In this technique a fixed
reduction potential is applied to the electrode and the
evolution of current with time is followed generating a
signal. The integration of this signal gives the amount
of charge exchanged in the process, which is signifi-
cantly larger for the perfectly hybridized sequences
when compared with sequences including one mis-
matched nucleotide (9, 10).
A cytochrome P450 3A4 (CYP3A4) electrochemical
DNA sensor was developed to identify the presence of
variant *1B alleles. CYP3A4 is the main drug-metabo-
lizing enzyme in human liver, being responsible for the
biotransformation of at least 50% of the currently avail-
able therapeutic drugs, such as antiarrhythmics, cyto-
statics, and antimalarials (20, 21). CYP3A4*1B was the
first variant described that has been proposed to affect
the enzyme concentration, to be associated with ad-
vanced stage prostate cancer (22), and to be protective
for secondary cancer caused by leukemia chemother-
apy (23).
Materials and Methods
All chemicals used were pro-analysis or equivalent purity
grade. Oligonucleotides (ODNs) were purchased from Invitro-
gen Corp. (Carlsbad, USA) or Hybaid (Interactiva Division,
Ulm, Germany).
Preparation of DNA-modified gold electrodes
Single-stranded modified gold electrodes were prepared by
immobilizing thiol-activated single-stranded oligonucleotides
(ssODN, designated by probe) designed on the basis of
the CYP3A4 gene sequence (Genbank accession number
AF280107). The CYP3A4*1B 17-mer probe sequence was de-
signed in order to locate the polymorphic locus (underlined
nucleotide) in the probe center and to have a melting temper-
ature close to 50 ºC. An additional requirement was the at-
tachment of a mercaptohexyl group (-SH(CH2)6-) at the 5´ end
to enable immobilization. The CYP3A4*1B 17-mer probe se-
quence used for immobilization is (5’-SH(CH2)6-CCTCTCTCCT-
GCCCTTG-3’)
A gold electrode (2 mm diameter, Metrohm, Herisau,
Switzerland) was cleaned by polishing the surface with an
electrode polishing kit (Metrohm, Herisau, Switzerland) con-
taining alumina. After polishing, the electrode was sonicated
for 5 min sequentially in a 65% (v/v) solution of nitric acid
(Riedel-de-Haen, Seelze, Germany), acetone (Riedel-de-Haen,
Seelze, Germany), and Milli-Q water. This cleaning procedure
was performed prior to each immobilization.
Cleaned electrodes were immersed overnight in 100 µl of a
5 µM probe solution in 100 mM phosphate buffer containing
100 mM NaCl, pH 7 (PBS buffer). After immobilization, the
electrode was rinsed with PBS buffer and then immersed in a
0.1 mM 2-mercapto-1-ethanol solution (Fluka, Buchs, Switzer-
land) – mercaptoethanol – for 90 min and rinsed again with
PBS buffer.
Double-stranded oligonucleotide (dsODN)-modified elec-
trodes were prepared by hybridizing the ssODN-modified
gold electrode with fully complementary (5’-CAAGGGCA-
GGAGAGAGG–3’) or single nucleotide mismatch sequence
(5’-CAAGGGCAAGAGAGAGG-3’), corresponding to the
CYP3A4*1B and *1A alleles, respectively. Hybridization reac-
tions were performed in a 100 µl solution of 50 nM target ODN
in PBS buffer for 270 min at room temperature.
Electrochemical measurements
CV and CC were performed using an Ecochemie Autolab
PGSTAT 12 potentiostat, and the results were analyzed using
the General Purpose Electrochemical System (GPES) soft-
ware, version 4.8 (Ecochemie B.V., Utrecht, The Netherlands).
A normal three-electrode configuration consisting of a modi-
fied, gold disk, working electrode, a homemade Ag/AgCl ref-
erence electrode, and a graphite counter electrode was used.
The supporting electrolyte (PBS buffer) was deoxygenated via
purging with nitrogen gas for 20 min, and the cell was blan-
keted with nitrogen during the experiments. CV was per-
formed between –0.5 and 1.25 V at a 0.1 V/s scan rate, in 0 to
8 µM methylene blue (MB; Fluka, Buchs, Switzerland), and 0 to
2.5 mM potassium hexacianoferrate (III) (Merck, Darmstadt,
Germany), hereafter designated ferrycianide. CC was per-
formed with a –0.4 V applied potential for 5 s, in 2 mM hexa-
cianoferrate (III) and 8 µM MB.
Three independent electrochemical experiments, either CV
or CC, were performed and average values, standard devia-
tions, and 95% confidence intervals for the mean values were
calculated.
Electrochemical detection of CYP3A4*1B in DNA samples
Genomic DNA was extracted from whole peripheral blood
samples (24), obtained during regular medical check-ups
upon informed consent and approval by the Ethical Boards of
the involved clinical institutions. The samples were tested for
the identification of the CYP3A4*1B single nucleotide poly-
morphism (SNP), which corresponds to an A→G transition at
–392 bp upstream of the transcription initiation site (22). A 124
bp fragment, in which the polymorphic site is located in a cen-
tral position, was amplified using the following primers (Invit-
rogen Corp. Carlsbad, USA): forward, 5’-TGT GGC TTG TTG
GGA TGA ATT TC-3’ and reverse, 5’-GGT TCT TAT CAG AAA
CTC AAG TGG-3’. Amplification was carried out in a reaction
mixture containing 2 µl of DNA (200–700 ng DNA), 1.5 mM
MgCl2, thermophilic DNA polymerase buffer (50 mM KCl,
10 mM Tris-HCl, pH 9.0, 0.1% Triton X-100), 0.2 mM of the four
deoxynucleotide triphosphates (Stratagene, La Jolla, USA),
2.5 units of Taq polymerase (Promega Corp., Madison, USA)
Figure 1 Schematic representation of the electrocatalytic cy-
cle for a DNA intercalator (methylene blue; MB) and an elec-
trochemically active compound (ferricyanide-[Fe(CN)6]3-)
through DNA double helix. LB: leukomethylene blue.
Marques et al.: Gene sensor for polymorphism detection 477
and 0.6 µM of each primer. Touchdown PCR amplification was
performed (Mastercycler 5332, Eppendorf, Germany) as fol-
lows: denaturation at 94 ºC for 2 min, followed by 7 cycles of
30 s at 56 ºC, 15 cycles of 45 s at 53ºC, 5 cycles of 45 s decreas-
ing 1 ºC/cycle from 52 ºC to 48 ºC, and 15 cycles 45 s at 48 ºC,
and a final extension step for 2 min at 72 ºC. An aliquot was an-
alyzed by polyacrylamide gel (8%) electrophoresis for 2 h at
200 V, to check for amplification efficiency and specificity.
The PCR product was diluted to a concentration of approxi-
mately 50 nM in PBS buffer and denatured at 90 ºC for 2 min.
After rapid cooling, the ssODN-modified electrode was im-
mersed in the solution (100 µl) for 270 min, so that the ampli-
con could hybridize with the immobilized probe. Electrochem-
ical measurements, CV, and CC were carried out with the
same parameters described above.
CYP3A4*1B detection by PCR-restriction fragment length
polymorphism (RFLP) analysis
Amplification was performed in a reaction mixture containing
2 µl of template DNA, 0.6 µM of each primer (Invitrogen Corp.,
Carlsbad, USA), forward, 5’-AAT GAG GAC AGC CAT AGA
GAC AAG GGC A-3’ and reverse, 5’-CAA TCA ATG TTA CTG
GGG AGT CCA AGG G–3’, 200 µM of each dNTP (Stratagene,
La Jolla, USA), 1.5 mM MgCl2, thermophilic DNA polymerase
buffer (50 mM KCl, 10 mM Tris-HCl, pH 9.0, 0.1% Triton X-100),
and 2.5 U of Taq DNA polymerase (Promega Corp., Madison,
USA). Thirty cycles of amplification were performed including
45 s denaturation at 94 ºC, 45 s annealing at 59 ºC, and 45 s ex-
tension at 72 ºC. The PCR product (122 bp) was digested with
5 U MvaI (Fermentas, Vilnius, Lithuania) for 3 h, at 37 ºC, and
analyzed by electrophoresis as before.
Results and Discussion
Gold electrode modification
DNA electrochemical sensors were prepared by im-
mersing the clean electrode overnight in 100 µl of a
5 µM solution of thiol-terminated ODNs. Chemi-ad-
sorption of thiol onto the gold surface is a fast process,
completed in 240 min (25), and leads to the formation
of densely packed monolayers with immobilized ODNs
oriented in an upright position with respect to the elec-
trode surface (25–27). The modified electrode was then
immersed in a mercaptoethanol solution in order to re-
move unbound ssODN as well as to promote correct
ssODN-surface orientation (25–27), and the dsODN
modified electrode was obtained by immersing the
ssODN-modified electrode in the target solution allow-
ing complementary hybridization to occur.
CV in PBS buffer was therefore performed as a con-
trol assay for the immobilization of ODNs and for the
follow-up of electrode hybridization and denaturation.
As shown in Figure 2, two peaks are present that corre-
spond to the gold oxide formation at the electrode sur-
face (approximately 1.1 V) and the respective reduction
peak (approximately 0.4 V) (28). Their intensities and
peak potentials change according to the modification
due to the different electrode surface status (Figure 2).
The higher intensity observed for the modified elec-
trodes suggests that higher amounts of oxides are
formed at the electrode surface, which could be due to
the higher electrostatic attraction of metal ions by the
negatively charged ODN layer (28). The intensity of
these peaks, however, decreased for the double-
stranded modified electrode. Although higher negative
charges are present near the electrode surface, dsODN-
modified electrodes are also more hindered and thus
less surface space is available for the accumulation of
metal ions (28). The different intensities of the oxide
peaks, especially the reduction peak, thus enable a
clear indication of electrode surface status, clean or
modified with ODN, as well as the identification of the
species immobilized (ss or dsODN).
Electrochemical genotyping – method development
In order to assess the potential identification of poly-
morphisms through charge transport along the dsODN
film, a catalytic electrochemical cycle was generated
using a DNA intercalator (MB) and a solution-borne
electron acceptor (ferricyanide; Figure 1) MB is a DNA
intercalator with pronounced electrochemical re-
sponse (reduction potential: –0.33 V). It binds at the top
of the immobilized dsODN film and is reduced by re-
ceiving the electrons flowing from the electrode sur-
face through the DNA pi-stack (9, 10, 29). Leukomethyl-
ene blue (LB), which is the reduced form of MB, will
then release the received electrons to reduce solution-
borne ferricyanide, returning to the initial oxidized
form (MB). The cycle continues as long MB can be re-
duced by electron flow, and is independent of the con-
centration of the involved species. Mismatched nu-
cleotides lead to base stacking interruptions and are
expected to have a pronounced effect on the observed
catalytic cycle due to the diminished electron flow
through the DNA film.
Ferricyanide is a negatively charged, electrochemi-
cally active compound and therefore is expected to be
repelled from the negatively charged dsODN film. Fer-
ricyanide is expected to be kept away from the elec-
trode surface and only residual electrochemical peaks
should be observed in CV. However, the ferricyanide
reduction/oxidation peaks at 0.20 V and 0.06 V, respec-
tively, observed in CV at dsODN-modified electrodes
(Figure 3A), are an indication that electrons are ex-
changed between solution-ferricyanide and the elec-
Figure 2 Cyclic voltammograms in buffer at bare gold elec-
trodes (curve A), gold electrodes modified with ssODN (curve
B), and dsODN (curve C).
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trode surface. The peaks’ intensity is linearly correlated
with ferricyanide concentration and is independent of
the MB concentration (Figure 3B).
CC can be used to monitor the electrochemical cat-
alytic cycle described above if the applied potential is
sufficient to guarantee the continuous reduction of the
intercalated MB. In CC, a fixed reductive potential is ap-
plied to the electrode and current evolution within a
certain time interval is integrated to obtain the charge
involved in the electrochemical process.
ODN-modified electrodes were hybridized with fully
complementary and mismatched synthetic ODN tar-
gets, and CC at –0.40 V of 2 mM ferricyanide in the pres-
ence of 8 µM MB was performed (Figure 4A). As ob-
served, the presence of a mismatched nucleotide leads
to a significant 2.6 µC charge attenuation (Figure 4A)
that increases linearly with time (Figure 4B). This is in-
dicative of the diminished DNA-mediated electron
transfer efficiency as a result of the local base stack per-
turbation (9, 10). Owing to the poor base stack, MB is
not efficiently reduced to generate and to maintain the
electrochemical catalytic cycle, which is reflected by re-
duced charge accumulation in CC (9, 10).
Charge accumulation (Q) at ssODN-modified elec-
trodes was also examined. As shown in Figure 4A, this
was the case with lower charge accumulation. This is
an expected result since a monolayer of mercap-
toethanol is formed at the electrode surface after ODN
immobilization in order to saturate the unoccupied sur-
face space. The CC activity at ssODN-modified elec-
trodes demonstrates that the monolayer formed was
not able to completely block the electrochemical activ-
ity of ferricyanide. Ferricyanide and MB can diffuse to
the electrode surface, and direct catalysis, not DNA-
mediated, occurs (9). The different charge transfer
mechanisms are clearly demonstrated by the different
slope and shape observed for the curves obtained
when using single- and double-stranded ODN-modi-
fied electrodes (9) (Figure 4). In some cases, however,
the curve obtained for the ssODN-modified electrode
had a similar magnitude to the perfectly matched hy-
brid (data not shown). This was interpreted as evidence
of the formation of an imperfect monolayer containing
holes where the gold surface is exposed to the buffer.
The electrode surface status, i.e., single- or double-
stranded modification, was always assessed by the
analysis of the gold oxide reduction peak (≈ 0.4 V) using
CV (Figure 2), performed prior the CC experiments.
This enabled the evaluation of the success of the hy-
bridization and avoided misinterpretation due to false
positives owing to possible hybridization failure.
In order to assess the method’s ability to discriminate
between homo- and heterozygotes, a solution of equal
amounts of fully complementary and mismatch ODNs
was prepared and hybridized to an ssODN-modified
electrode. As expected, accumulated charges were sit-
Figure 3 (A) Cyclic voltammograms for increasing ferri-
cyanide concentration at dsODN-modified electrodes in PBS
buffer. (B) Ferricyanide reduction peak intensity variation with
ferricyanide concentration at dsODN-modified electrodes in
PBS buffer containing 0 µM (open circles); 0.25 µM (dark dia-
monds); 0.5 µM (open diamonds); 1.0 µM (dark triangles);
2.0 µM (open triangles), and 4.0 µM (dark circles) methylene
blue.
Figure 4 (A) Chronocoulometry at –0.4 V for 5 s in 2.0 mM of
ferricyanide and 8 µM MB+ for ssODN-modified electrode
(solid line), ssODN-modified electrode hybridized with fully
complementary oligonucleotide (open circles), and ssODN-
modified electrode hybridized with mismatched oligonu-
cleotide (closed circles). (B) Accumulated charge difference
for fully complementary and mismatched samples.
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uated between the two limits of fully complementary
and mismatched ODNs (Figure 4A), suggesting that the
method developed has the potential to discriminate
heterozygotes.
Electrochemical genotyping – method validation and
testing
In order to develop an alternative method for genotyp-
ing, the methodology must be validated with samples
previously genotyped by standard methods (e.g.,
PCR/RFLP). As such, ODN primers were designed to
amplify a 124 bp fragment of the CYP3A4 gene locating
the targeted polymorphic loci in the amplicon center.
Amplicons obtained from genomic DNA samples were
genotyped by RFLP (Figure 5) and hybridized to
ssODN-modified electrodes. After washing the elec-
trode to remove unhybridized DNA, CV in buffer was
performed to investigate the type of the monolayer
film at the electrode surface (i.e., single- or double-
stranded DNA film), and electrochemical genotyping
was performed by measuring the charge accumulation
(Q) after 5 s in 2 mM ferricyanide and 8 µM MB.
Figure 6 shows the characteristic charge accumu-
lated at the electrode surface after 5 s for homozygotes
for CYP3A4*1A (genotype *1A/*1A) and CYP3A4*1B
(genotype *1B/*1B) variants, as well as for heterozy-
gotes for the mutation (genotype *1A/*1B). Since the
immobilized ODN (probe) was designed in order to be
fully complementary for the *1B variant, mismatched
hybrids were obtained after hybridizing the electrode
with *1A samples. Therefore, samples presenting less
charge accumulation correspond to *1A samples. As
previously mentioned, for heterozygotes the ratio of
fully complementary/mismatch is equal. This is re-
flected in CC by the intermediate overall charge accu-
mulation observed (Figure 6).
The 95% confidence intervals for the mean charge
accumulated (Q) at the electrode surface after 5 s for
triplicate chronocoulometric measurements of previ-
ously genotyped DNA samples are presented in
Table 1. As shown (Table 1), the electrochemical geno-
typing methodology can distinguish CYP3A4*1A ho-
mozygotes, CYP3A4*1A/CYP3A4*1B heterozygotes,
and CYP3A4*1B homozygotes. The 95% confidence in-
tervals for the mean of the average charge accumu-
lated at the electrode surface are Qm = –26.5±0.07 µC,
Qm = –30.8±0.06 µC, and Qm = –33.59±0.02 µC for *1A
homozygotes, *1A/*1B heterozygotes, and *1B ho-
mozygotes, respectively. These values correspond to
Figure 5 Polyacrylamide gel (8%) of a typical RFLP analysis.
PCR products were analyzed before (–) (lane 2) and after (+) di-
gestion with MvaI.Typical restriction patterns are shown for
CYP3A4*1A/*1A, *1A/*1B, and *1B/*1B genotypes. MvaI di-
gestion of the 122 bp PCR product gives rise to two fragments
(97 bp and 25 bp) in the CYP3A4 *1B variant. MW: molecular
weight marker: Φx174 digested with HinfI.
Figure 6 Chronocoulometry at –0.4 V for 5 s in 2.0 mM of
ferrycianide-and 8 µM MB+ at ssODN-modified electrode
hybridized with CYP3A4*1B homozygotes (open triangles),
CYP3A4*1B/*1A heterozygotes (closed squares), and
CYP3A4*1A homozygotes (closed circles).
Table 1 95% Confidence intervals for the mean charge accu-
mulated (Q ± σ) at the electrode surface for previously geno-
typed samples by RFLP and 95% confidence intervals for the
mean of the average charge accumulated (Qm±σm) for
CYP3A4*1A homozygotes, CYP3A4*1A/CYP3A4*1B heterozy-
gotes, and CYP3A4*1B homozygotes.
Sample RFLP Q±σ Qm±σm
genotyping (µC) (µC)
# 1 *1A/*1A –27.89±0.01 –26.5±0.07
# 2 *1A/*1A –23.7±0.06
# 3 *1A/*1A –25.54±0.04
# 4 *1A/*1A –27.6±0.06
# 5 *1A/*1B –30.22±0.03 –30.8±0.06
# 6 *1A/*1B –30.18±0.02
# 7 *1A/*1B –29.13±0.04
# 8 *1A/*1B –33.91±0.02
# 9 *1A/*1B –31.30±0.03
# 10 *1B/*1B –33.59±0.02 –33.59±0.02
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7.1±0.09 µC and 2.8±0.08 µC decreases for *1A ho-
mozygotes and *1A/*1B heterozygotes, respectively,
when compared with the fully complementary hybrid
formed at the electrode surface for *1B homozygote
samples. Although these are significant differences,
only one previously genotyped *1B homozygote sam-
ple was available for method validation (Table 1).
Therefore, in order to ensure statistical significance of
sensors’ sample classification, electrochemical geno-
typing methodology was used to distinguish *1A ho-
mozygotes from samples containing at least one *1B
allele (i.e., heterozygotes or homozygotes for the poly-
morphism). Electrochemical sample classification was
performed on the basis of normal distributions with the
(average; standard deviation) parameters (26.5; 1.91)
and (31.4; 1.95) for CYP3A4*1A homozygotes (vali-
dated with 4 samples and 12 independent measure-
ments; Table 1) and for samples containing at least one
*1B allele (validated with 6 samples and 18 indepen-
dent measurements; Table 1), respectively.
A blind assay was performed to test the methodol-
ogy developed. Sixteen samples were genotyped inde-
pendently by the electrochemical method and by RFLP
(Table 2). Both electrochemical and RFLP genotyping
gave similar results for CYP3A4*1A homozygotes con-
sidering two possible classifications: *1A homozy-
gotes and samples containing at least one *1B allele.
This discrimination failed only for one case (sample
#17, Table 2), corresponding to a 6.25% failure fre-
quency (Table 2).
In summary, an electrochemical genotyping method-
ology was developed with synthetic ODNs, validated
with previously genotyped DNA samples and tested
with DNA extracted from human subjects. The method-
ology developed was able to identify CYP3A4*1A ho-
mozygotes as well as samples containing at least one
CYP3A4*1B allele. Furthermore, the method is fast (5 s)
and reproducible. However, at this stage the method
was not able to differentiate CYP3A4*1B homo- and
heterozygotes. This apparent failure is due to poor dis-
criminating power owing to the proximity of the accu-
mulated charge curves for homozygotes *1A and *1B.
Efforts are being undertaken to further optimize the
methodology in order to enable full genotyping capac-
ity by discriminating homozygotes and heterozygotes.
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